# David Dingli

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-dingli/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,598 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 89 |
| i10-index | 429 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5007747233 |
| ORCID iD | https://orcid.org/0000-0001-7477-3004 |
| Works | 1,101 |

## Researcher papers

- [Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma](https://scholariq.org/papers/oral-selinexor-dexamethasone-for-triple-class-refractory-multiple-myeloma/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.